Aptevo Therapeutics Inc. — Director's Dealing 2018

Feb 7, 2018

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Aptevo Therapeutics Inc. (APVO)
CIK: 0001671584
Period of Report: 2018-02-03

Reporting Person: Lamothe Jeffrey G. (SVP, CFO and Treasurer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2018-02-03	Common Stock	M	25340	—	Acquired	66623	Direct
2018-02-03	Common Stock	F	7514	$3.24	Disposed	59109	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2018-02-03	Restricted Stock Unit	$	M	25340	Disposed		Common Stock (25340)	Direct

Footnotes

F1: Each RSU converts into the Issuer's common stock on a one-for-one basis.

F2: On August 3, 2016, the reporting person was granted 50,680 RSUs, vesting in two equal installments on February 3, 2017 and February 3, 2018.